Cargando…

Natural Progression of Routine Laboratory Markers after Spinal Trauma: A Longitudinal, Multi-Cohort Study

Our objective was to track and quantify the natural course of serological markers over the 1st year following spinal cord injury. For that purpose, data on serological markers, demographics, and injury characteristics were extracted from medical records of a clinical trial (Sygen) and an ongoing obs...

Descripción completa

Detalles Bibliográficos
Autores principales: Bourguignon, Lucie, Vo, Anh Khoa, Tong, Bobo, Geisler, Fred, Mach, Orpheus, Maier, Doris, Kramer, John L.K., Grassner, Lukas, Jutzeler, Catherine R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309438/
https://www.ncbi.nlm.nih.gov/pubmed/33882712
http://dx.doi.org/10.1089/neu.2021.0012
_version_ 1783728521676324864
author Bourguignon, Lucie
Vo, Anh Khoa
Tong, Bobo
Geisler, Fred
Mach, Orpheus
Maier, Doris
Kramer, John L.K.
Grassner, Lukas
Jutzeler, Catherine R.
author_facet Bourguignon, Lucie
Vo, Anh Khoa
Tong, Bobo
Geisler, Fred
Mach, Orpheus
Maier, Doris
Kramer, John L.K.
Grassner, Lukas
Jutzeler, Catherine R.
author_sort Bourguignon, Lucie
collection PubMed
description Our objective was to track and quantify the natural course of serological markers over the 1st year following spinal cord injury. For that purpose, data on serological markers, demographics, and injury characteristics were extracted from medical records of a clinical trial (Sygen) and an ongoing observational cohort study (Murnau study). The primary outcomes were concentration/levels/amount of commonly collected serological markers at multiple time points. Two-way analysis of variance (ANOVA) and mixed-effects regression techniques were used to account for the longitudinal data and adjust for potential confounders. Trajectories of serological markers contained in both data sources were compared using the slope of progression. Our results show that, at baseline (≤ 2 weeks post-injury), most serological markers were at pathological levels, but returned to normal values over the course of 6–12 months post-injury. The baseline levels and longitudinal trajectories were dependent on injury severity. More complete injuries were associated with more pathological values (e.g., hematocrit, ANOVA test; χ(2) = 68.93, df = 3, adjusted p value <0.001, and χ(2) = 73.80, df = 3, adjusted p value <0.001, in the Sygen and Murnau studies, respectively). Comparing the two databases revealed some differences in the serological markers, which are likely attributable to differences in study design, sample size, and standard of care. We conclude that because of trauma-induced physiological perturbations, serological markers undergo marked changes over the course of recovery, from initial pathological levels that normalize within a year. The findings from this study are important, as they provide a benchmark for clinical decision making and prospective clinical trials. All results can be interactively explored on the Haemosurveillance web site (https://jutzelec.shinyapps.io/Haemosurveillance/) and GitHub repository (https://github.com/jutzca/Systemic-effects-of-Spinal-Cord-Injury).
format Online
Article
Text
id pubmed-8309438
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Mary Ann Liebert, Inc., publishers
record_format MEDLINE/PubMed
spelling pubmed-83094382021-07-26 Natural Progression of Routine Laboratory Markers after Spinal Trauma: A Longitudinal, Multi-Cohort Study Bourguignon, Lucie Vo, Anh Khoa Tong, Bobo Geisler, Fred Mach, Orpheus Maier, Doris Kramer, John L.K. Grassner, Lukas Jutzeler, Catherine R. J Neurotrauma Original Articles Our objective was to track and quantify the natural course of serological markers over the 1st year following spinal cord injury. For that purpose, data on serological markers, demographics, and injury characteristics were extracted from medical records of a clinical trial (Sygen) and an ongoing observational cohort study (Murnau study). The primary outcomes were concentration/levels/amount of commonly collected serological markers at multiple time points. Two-way analysis of variance (ANOVA) and mixed-effects regression techniques were used to account for the longitudinal data and adjust for potential confounders. Trajectories of serological markers contained in both data sources were compared using the slope of progression. Our results show that, at baseline (≤ 2 weeks post-injury), most serological markers were at pathological levels, but returned to normal values over the course of 6–12 months post-injury. The baseline levels and longitudinal trajectories were dependent on injury severity. More complete injuries were associated with more pathological values (e.g., hematocrit, ANOVA test; χ(2) = 68.93, df = 3, adjusted p value <0.001, and χ(2) = 73.80, df = 3, adjusted p value <0.001, in the Sygen and Murnau studies, respectively). Comparing the two databases revealed some differences in the serological markers, which are likely attributable to differences in study design, sample size, and standard of care. We conclude that because of trauma-induced physiological perturbations, serological markers undergo marked changes over the course of recovery, from initial pathological levels that normalize within a year. The findings from this study are important, as they provide a benchmark for clinical decision making and prospective clinical trials. All results can be interactively explored on the Haemosurveillance web site (https://jutzelec.shinyapps.io/Haemosurveillance/) and GitHub repository (https://github.com/jutzca/Systemic-effects-of-Spinal-Cord-Injury). Mary Ann Liebert, Inc., publishers 2021-08-01 2021-07-15 /pmc/articles/PMC8309438/ /pubmed/33882712 http://dx.doi.org/10.1089/neu.2021.0012 Text en © Lucie Bourguignon et al., 2021; Published by Mary Ann Liebert, Inc. https://creativecommons.org/licenses/by-nc/4.0/This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (CC-BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Original Articles
Bourguignon, Lucie
Vo, Anh Khoa
Tong, Bobo
Geisler, Fred
Mach, Orpheus
Maier, Doris
Kramer, John L.K.
Grassner, Lukas
Jutzeler, Catherine R.
Natural Progression of Routine Laboratory Markers after Spinal Trauma: A Longitudinal, Multi-Cohort Study
title Natural Progression of Routine Laboratory Markers after Spinal Trauma: A Longitudinal, Multi-Cohort Study
title_full Natural Progression of Routine Laboratory Markers after Spinal Trauma: A Longitudinal, Multi-Cohort Study
title_fullStr Natural Progression of Routine Laboratory Markers after Spinal Trauma: A Longitudinal, Multi-Cohort Study
title_full_unstemmed Natural Progression of Routine Laboratory Markers after Spinal Trauma: A Longitudinal, Multi-Cohort Study
title_short Natural Progression of Routine Laboratory Markers after Spinal Trauma: A Longitudinal, Multi-Cohort Study
title_sort natural progression of routine laboratory markers after spinal trauma: a longitudinal, multi-cohort study
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309438/
https://www.ncbi.nlm.nih.gov/pubmed/33882712
http://dx.doi.org/10.1089/neu.2021.0012
work_keys_str_mv AT bourguignonlucie naturalprogressionofroutinelaboratorymarkersafterspinaltraumaalongitudinalmulticohortstudy
AT voanhkhoa naturalprogressionofroutinelaboratorymarkersafterspinaltraumaalongitudinalmulticohortstudy
AT tongbobo naturalprogressionofroutinelaboratorymarkersafterspinaltraumaalongitudinalmulticohortstudy
AT geislerfred naturalprogressionofroutinelaboratorymarkersafterspinaltraumaalongitudinalmulticohortstudy
AT machorpheus naturalprogressionofroutinelaboratorymarkersafterspinaltraumaalongitudinalmulticohortstudy
AT maierdoris naturalprogressionofroutinelaboratorymarkersafterspinaltraumaalongitudinalmulticohortstudy
AT kramerjohnlk naturalprogressionofroutinelaboratorymarkersafterspinaltraumaalongitudinalmulticohortstudy
AT grassnerlukas naturalprogressionofroutinelaboratorymarkersafterspinaltraumaalongitudinalmulticohortstudy
AT jutzelercatheriner naturalprogressionofroutinelaboratorymarkersafterspinaltraumaalongitudinalmulticohortstudy